The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 21, 2017

Filed:

Jul. 04, 2012
Applicants:

Kazuya Omi, Tokyo, JP;

Tsuyoshi Ando, Tokyo, JP;

Yoshiaki Uchida, Tokyo, JP;

Katsutoshi Goishi, Tokyo, JP;

Yoshie Goishi, Tokyo, JP;

Asako Oka, Tokyo, JP;

Takashi Shirakawa, Tokyo, JP;

Takuya Sakyu, Tokyo, JP;

Inventors:

Kazuya Omi, Tokyo, JP;

Tsuyoshi Ando, Tokyo, JP;

Yoshiaki Uchida, Tokyo, JP;

Katsutoshi Goishi, Tokyo, JP;

Asako Oka, Tokyo, JP;

Takashi Shirakawa, Tokyo, JP;

Takuya Sakyu, Tokyo, JP;

Assignee:

FUJIREBIO INC., Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/44 (2006.01); C07K 16/26 (2006.01); G01N 33/543 (2006.01); G01N 33/531 (2006.01); G01N 33/74 (2006.01); G01N 33/78 (2006.01); G01N 33/82 (2006.01);
U.S. Cl.
CPC ...
G01N 33/54306 (2013.01); C07K 16/26 (2013.01); C07K 16/44 (2013.01); G01N 33/531 (2013.01); G01N 33/743 (2013.01); G01N 33/78 (2013.01); G01N 33/82 (2013.01); C07K 2317/24 (2013.01); C07K 2317/32 (2013.01); C07K 2317/92 (2013.01);
Abstract

The present invention provides a means and a method for specifically measuring a substance such as a small substance with high sensitivity by a sandwich method. Specifically, the present invention provides an antibody capable of specifically binding to an affinity complex and a method of measuring of the affinity complex comprising measuring the affinity complex using the antibody capable of specifically binding to the affinity complex. The antibody of the present invention may be a full-length antibody. The antibody of the present invention may also have a region derived from an immunoglobulin from an animal having an ability of gene conversion (e.g., a complementarity-determining region, a framework region, or a variable region). Examples of at least one factor that constitutes the affinity complex include a small substance or a protein (e.g., antibody).


Find Patent Forward Citations

Loading…